[go: up one dir, main page]

Petros et al., 2000 - Google Patents

Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies

Petros et al., 2000

View PDF
Document ID
1725825672710693726
Author
Petros A
Nettesheim D
Wang Y
Olejniczak E
Meadows R
Mack J
Swift K
Matayoshi E
Zhang H
Thompson C
Fesik S
Publication year
Publication venue
Protein Science

External Links

Snippet

The three-dimensional structure of the anti-apoptotic protein Bcl-xL complexed to a 25- residue peptide from the death promoting region of Bad was determined using NMR spectroscopy. Although the overall structure is similar to Bcl-xL bound to a 16-residue …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci

Similar Documents

Publication Publication Date Title
Petros et al. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies
Osawa et al. Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition
Pelton et al. Solution structure of the DNA-binding domain of NtrC with three alanine substitutions
Kuboniwa et al. Solution structure of calcium-free calmodulin
Byeon et al. A protein contortionist: core mutations of GB1 that induce dimerization and domain swapping
Huang et al. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2
Day et al. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1
Pan et al. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor
Denisov et al. Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix
Cowley et al. Structure of neuropeptide Y dimer in solution
Januszyk et al. Identification and solution structure of a highly conserved C-terminal domain within ORF1p required for retrotransposition of long interspersed nuclear element-1
Chen et al. Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription
Garcia‐Herrero et al. The solution structure of the periplasmic domain of the TonB system ExbD protein reveals an unexpected structural homology with siderophore‐binding proteins
Siegal et al. Solution structure of the C-terminal SH2 domain of the p85α regulatory subunit of phosphoinositide 3-kinase
Colpan et al. Localization of the binding interface between leiomodin-2 and α-tropomyosin
Blanco et al. High populations of non-native structures in the denatured state are compatible with the formation of the native folded state
Bertelsen et al. Topology and dynamics of the 10 kDa C‐terminal domain of DnaK in solution
Vincenzi et al. NMR spectroscopy in the conformational analysis of peptides: an overview
Muskett et al. The Solution Structure of Bovine Ferricytochromeb5Determined Using Heteronuclear NMR Methods
Hegedüs et al. Identification of β-strand mediated protein–protein interaction inhibitors using ligand-directed fragment ligation
Matsuo et al. Three-dimensional dimer structure of the λ-Cro repressor in solution as determined by heteronuclear multidimensional NMR
Zhang et al. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1
Horita et al. Solution structure of the human Hck SH3 domain and identification of its ligand binding site
Eisenmann et al. The E. coli NusA carboxy‐terminal domains are structurally similar and show specific RNAP‐and λN interaction
Kang et al. Identification and structural characterization of a CBP/p300-binding domain from the ETS family transcription factor GABPα